QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
NYSE:STE

STERIS (STE) Stock Forecast, Price & News

$215.50
-3.92 (-1.79%)
(As of 10/2/2023 ET)
Compare
Today's Range
$214.05
$218.16
50-Day Range
$217.82
$233.08
52-Week Range
$159.21
$254.00
Volume
445,180 shs
Average Volume
447,308 shs
Market Capitalization
$21.29 billion
P/E Ratio
176.64
Dividend Yield
0.97%
Price Target
$239.60

STERIS MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.60 Rating Score
Upside/​Downside
11.2% Upside
$239.60 Price Target
Short Interest
Bearish
1.52% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-2.00
Upright™ Environmental Score
News Sentiment
0.61mentions of STERIS in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.58%
From $8.74 to $9.49 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.20 out of 5 stars

Medical Sector

771st out of 969 stocks

Surgical Appliances & Supplies Industry

15th out of 20 stocks


STE stock logo

About STERIS (NYSE:STE) Stock

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

STE Price History

STE Stock News Headlines

The Elites Are Waging War on Elon Musk — Here's Why…
Elon has helped unleash an opportunity that could create trillions in wealth for everyday Americans. So why does the deep state hate him for it?
STERIS's (STE) Overweight Rating Reaffirmed at Stephens
Steris PLC stock rises Monday, outperforms market
Q1 2025 EPS Estimates for STERIS plc Lowered by Analyst (NYSE:STE)
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
JMP Securities Reaffirms Their Buy Rating on Steris (STE)
Steris PLC stock rises Tuesday, outperforms market
STERIS plc (NYSE:STE) Q1 2024 Earnings Call Transcript
Steris (STE) Declares $0.52 Dividend
Q1 2024 STERIS plc Earnings Call
Steris: Fiscal Q1 Earnings Snapshot
See More Headlines
Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

STE Company Calendar

Last Earnings
8/01/2023
Ex-Dividend for 9/22 Dividend
9/05/2023
Dividend Payable
9/22/2023
Today
10/02/2023
Next Earnings (Estimated)
11/08/2023
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
85915210
Employees
17,100
Year Founded
1987

Price Target and Rating

Average Stock Price Forecast
$239.60
High Stock Price Forecast
$265.00
Low Stock Price Forecast
$200.00
Forecasted Upside/Downside
+11.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

Net Income
$107.03 million
Pretax Margin
3.55%

Debt

Sales & Book Value

Annual Sales
$4.96 billion
Cash Flow
$18.53 per share
Book Value
$61.31 per share

Miscellaneous

Free Float
97,843,000
Market Cap
$21.29 billion
Optionable
Optionable
Beta
0.86

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Daniel A. CarestioMr. Daniel A. Carestio (Age 50)
    Pres, CEO & Director
    Comp: $1.59M
  • Mr. Michael J. TokichMr. Michael J. Tokich (Age 54)
    Sr. VP & CFO
    Comp: $838.61k
  • Mr. John Adam ZangerleMr. John Adam Zangerle (Age 56)
    Sr. VP, Gen. Counsel & Sec.
    Comp: $718.45k
  • Ms. Mary Clare Fraser (Age 53)
    SVP & Chief HR Officer
    Comp: $555.75k
  • Mr. Cary L. Majors (Age 48)
    Sr. VP & Pres of Healthcare
    Comp: $615.61k
  • Ms. Karen L. BurtonMs. Karen L. Burton (Age 55)
    Chief Accounting Officer, VP & Controller
  • Julie Winter
    VP of Investor Relations & Corp. Communications
  • Mr. Walter M. Rosebrough Jr.Mr. Walter M. Rosebrough Jr. (Age 69)
    CEO Emeritus & Sr. Advisor
  • Ms. Julia K. Madsen (Age 58)
    Sr. VP of Life Sciences
  • Mr. Andrew Xilas (Age 58)
    Sr. VP & GM of Dental













STE Stock - Frequently Asked Questions

Should I buy or sell STERIS stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" STE shares.
View STE analyst ratings
or view top-rated stocks.

What is STERIS's stock price forecast for 2023?

5 Wall Street research analysts have issued 12 month price targets for STERIS's shares. Their STE share price forecasts range from $200.00 to $265.00. On average, they anticipate the company's stock price to reach $239.60 in the next twelve months. This suggests a possible upside of 11.2% from the stock's current price.
View analysts price targets for STE
or view top-rated stocks among Wall Street analysts.

How have STE shares performed in 2023?

STERIS's stock was trading at $184.69 at the start of the year. Since then, STE shares have increased by 16.7% and is now trading at $215.50.
View the best growth stocks for 2023 here
.

Are investors shorting STERIS?

STERIS saw a decline in short interest in August. As of August 31st, there was short interest totaling 1,480,000 shares, a decline of 17.8% from the August 15th total of 1,800,000 shares. Based on an average trading volume of 385,000 shares, the days-to-cover ratio is presently 3.8 days. Approximately 1.5% of the company's stock are sold short.
View STERIS's Short Interest
.

When is STERIS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our STE earnings forecast
.

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) posted its earnings results on Tuesday, August, 1st. The medical equipment provider reported $2.00 earnings per share for the quarter, topping analysts' consensus estimates of $1.86 by $0.14. The medical equipment provider earned $1.28 billion during the quarter, compared to the consensus estimate of $1.21 billion. STERIS had a trailing twelve-month return on equity of 13.75% and a net margin of 2.35%. The firm's quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the prior year, the business earned $1.90 EPS.
Read the conference call transcript
.

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS declared a quarterly dividend on Wednesday, July 26th. Investors of record on Wednesday, September 6th will be given a dividend of $0.52 per share on Friday, September 22nd. This represents a $2.08 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date of this dividend is Tuesday, September 5th. This is a positive change from the stock's previous quarterly dividend of $0.47.
Read our dividend analysis for STE
.

Is STERIS a good dividend stock?

STERIS (NYSE:STE) pays an annual dividend of $2.08 per share and currently has a dividend yield of 0.95%. The company has been increasing its dividend for 18 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 170.49%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, STE will have a dividend payout ratio of 21.92% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for STE.

What guidance has STERIS issued on next quarter's earnings?

STERIS issued an update on its FY 2024 earnings guidance on Tuesday, August, 1st. The company provided earnings per share (EPS) guidance of $8.60-$8.80 for the period, compared to the consensus EPS estimate of $8.68. The company issued revenue guidance of $5.40 billion-$5.45 billion, compared to the consensus revenue estimate of $5.33 billion.

What is Walter M. Rosebrough, Jr.'s approval rating as STERIS's CEO?

196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees.

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

What is STERIS's stock symbol?

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

How do I buy shares of STERIS?

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STERIS's stock price today?

One share of STE stock can currently be purchased for approximately $215.50.

How much money does STERIS make?

STERIS (NYSE:STE) has a market capitalization of $21.29 billion and generates $4.96 billion in revenue each year. The medical equipment provider earns $107.03 million in net income (profit) each year or $1.22 on an earnings per share basis.

How many employees does STERIS have?

The company employs 17,100 workers across the globe.

How can I contact STERIS?

STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The official website for the company is www.steris.com. The medical equipment provider can be reached via phone at (440) 354-2600, via email at julie_winter@steris.com, or via fax at 440-639-4457.

This page (NYSE:STE) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -